Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-24

Clinical Trial Update: Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing [NA]

View source ↗

Summary

A clinical trial evaluating clonidine to prevent implantable cardioverter-defibrillator firing has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)

Snippet

Sponsor: James Martins | Conditions: Ventricular Tachycardia | NA | Status: WITHDRAWN